Delays in Follow-up after a Positive Lung Cancer Screening Exam: Is the Benefit of Screening Compromised?
Ann Am Thorac Soc
.
2023 Aug;20(8):1102-1104.
doi: 10.1513/AnnalsATS.202305-440ED.
Authors
M Patricia Rivera
1
2
,
Louise M Henderson
3
4
,
Lori C Sakoda
5
6
Affiliations
1
Division of Pulmonary and Critical Care Medicine, University of Rochester Medical Center, Rochester, New York.
2
Wilmot Cancer Institute, University of Rochester, Rochester, New York.
3
Department of Radiology, and.
4
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
5
Division of Research, Kaiser Permanente Northern California, Oakland, California; and.
6
Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
PMID:
37311217
PMCID:
PMC10405616
DOI:
10.1513/AnnalsATS.202305-440ED
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Early Detection of Cancer
Follow-Up Studies
Humans
Lung Neoplasms* / diagnostic imaging
Mass Screening
Grants and funding
R01 CA212014/CA/NCI NIH HHS/United States
R01 CA251686/CA/NCI NIH HHS/United States